Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
15.8M
-
Shares change
-
-1.94M
-
Total reported value, excl. options
-
$109M
-
Value change
-
-$42.8M
-
Number of buys
-
31
-
Number of sells
-
-45
-
Price
-
$6.92
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2016
92 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q4 2016.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.8M shares
of 386M outstanding shares and own 4.08% of the company stock.
Largest 10 shareholders include Paradice Investment Management LLC (1.63M shares), HEARTLAND ADVISORS INC (1.53M shares), Boston Partners (1.5M shares), JANUS CAPITAL MANAGEMENT LLC (1.42M shares), Lapides Asset Management, LLC (1.17M shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (884K shares), STONEHILL CAPITAL MANAGEMENT LLC (739K shares), 22NW, LP (720K shares), MILLENNIUM MANAGEMENT LLC (573K shares), and Senvest Management, LLC (462K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.